Navigation Links
Frost & Sullivan Recognizes Precise Biometrics as a Key Player in the Non-AFIS Fingerprint Market
Date:10/20/2008

MOUNTAIN VIEW, Calif., Oct. 20 /PRNewswire/ -- Based on its recent analysis of the non-AFIS (Automated Fingerprint Identification System) fingerprint market, Frost & Sullivan recognizes Precise Biometrics with the 2008 Global Frost & Sullivan Award for Emerging Company of the Year for its high-quality authentication method, Precise Match-on-Card(TM).

Precise Biometrics offers a software combination of smart card and fingerprint technology demonstrating superior performance and extremely secure and accurate authentication. The company has offered its core technology, Precise BioMatch(TM), since 1999. Precise BioMatch(TM), in combination with smart cards, is used to create the secure, highly accurate Precise Match-on-Card(TM) system, which both stores and matches fingerprints on a smart card. It not only replaces personal identification numbers and passwords but also makes use of the secure environment of the chip.

Frost & Sullivan Research Analyst Neelima Sagar noted, "Exceptional customer service and support, technical expertise, and strategic alliances and partnerships have contributed to the success of Precise Biometrics. The company has been able to serve its customers globally because of its trustworthy relationships with its partners."

Precise Match-on-Card(TM) offers several key differentiating factors that ensure its security as well as its excellent level of customer satisfaction. The interoperability of the system allows each client to tailor the requirements of readers, smart cards and applications based on specific budgets and needs. The security is based on the smart card security infrastructure. The card integrity and the user privacy are preserved due to matching decisions being taken entirely inside the card. The logic remains identical to on-card PIN verification. Therefore, the scalability, flexibility, security and ease of deployment, for which the smart card is so justly appreciated, is maintained with the introduction
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology news :

1. Peat and forests save permafrost from melting
2. Will global warming increase plant frost damage?
3. Atmel Receives Frost & Sullivans Technology Innovation Award for FingerChip(R) Biometric Sensor
4. Thawing permafrost likely to boost global warming
5. Bad sign for global warming: Thawing permafrost holds vast carbon pool
6. Frost & Sullivan Recognizes AOptix Technologies for its Pioneering Contribution to Security through Noninvasive Biometrics
7. UNCCD recognizes importance of satellites for combating desertification
8. Entomological Society of America recognizes 2007 fellows and honorary members
9. NIH recognizes Clemson nanotechnology for molecule tracking
10. EMBO recognizes German zoologist for public communication
11. The precise role of seminal proteins in sustaining post-mating responses in fruit flies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... one of your muscles can twitch, before the though...iny floodgate of sortscalled an ion channelmust op...let in the chemical signals that spur the cell to ... Standards and Technology (NIST) has allowed scien...embrane for the first time, potentially offering i...
(Date:12/2/2009)..., NY, December 2, 2009 Commonly prescribed beta 2...hma in pregnant women as well as pre-term labor ma...ers, psychiatric pathology, cognitive problems and...ing to a new study published in the December 2009 ...ecology . , Beta 2 adrenergic agonist drugs as a...
(Date:12/2/2009)...Hall, a PhD student at the University of Southampt...he National Oceanography Centre, Southampton (NOCS...crab, all from the deep sea. , Hall discovered t...he National Museum of Natural History in Washingto...id: "King crabs include some of the largest crusta...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2King crab family bigger than ever 2Authentidate Holding Corp to Report Fiscal 2010 First Quarter Results on Monday November 16 2009 61295 1Authentidate Holding Corp to Report Fiscal 2010 First Quarter Results on Monday November 16 2009 61295 2Soligenix Reports Third Quarter 2009 Financial Results 14827 1Soligenix Reports Third Quarter 2009 Financial Results 14827 2Soligenix Reports Third Quarter 2009 Financial Results 14827 3Soligenix Reports Third Quarter 2009 Financial Results 14827 4Soligenix Reports Third Quarter 2009 Financial Results 14827 5Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement 6245 1Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement 6245 2
... biodegradable polymers called polyketals and thei...mmatory illnesses as acute lung injury, acute live...ring drugs, proteins and snips of ribonucleic acid...al microparticles we developed are simply a vehicl... area as quickly as possible," said Niren Murthy, ...
...l Human Genome Research Institute (NHGRI), part of...arded more than $20 million in grants to develop i...efficient enough to sequence a person,s DNA as a r.... , "The ability to comprehensively sequence any...d to usher in an age of personalized medicine wher...
...to unravel gonadotrophs , Although the basic de...nown, it has been harder to associate specific cha... limited cell population. In an article on p. 546 ...uction , Feng et al. take the approach of comparin...nes that were immortalized at different stages of ...
Other Biology News:Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 2NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 5September 2008 Biology of Reproduction highlights 2
(Date:12/2/2009)...ecember 2 Gamida Cell announced to... (animal study) safety and,efficacy of a gene ther...ornell Medical College and Gamida Cell. The produc...ch as Cooley,s Anemia. , Gamida Cell is d...ivo,populations of stem/progenitor cells. The com...
(Date:12/2/2009)...wire-Asia/ -- The world is going through,extraordi... is part of many,businesses and industries. It tur...y immune to the economic downturn, because illness...dst of the difficult times this year, the pharmace...R&D center in Shanghai, the largest of,its kin...
(Date:12/1/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Chromium - Global Market Trends ,, h...bal-Market-Trends.html ,, Worldwide demand for...el, while growth in aerospace and industrial gas t...omium metal. Environmental constraints and rapid d...
(Date:12/1/2009)...hard Gephardt Brings Together A-List from New Jers...Best and Brightest Forum on Medical Innovation" ...wire/ -- Several of New Jersey,s most prominent le...d technology gathered today at the Liberty Science...ation in New Jersey, and throughout the United Sta...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5
...How Organizations Can Make the Transition to SPL R...uring Virtify, Inc. , , CAMBRIDGE, Mass., April ...t leader in Enterprise Content Compliance solution...ilgrimsoftware.com ), a provider of Enterprise Co...lutions, will host a complimentary Webinar on bes...
...Call/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ...sults for the first quarter ended March 31, 2009. ...irst quarter in what has been a difficult business... Hunter, President and CEO of Angiotech. "Sales in...ess areas continued to show very promising growth,...
... Inc. has announced today that it has entered into...al, Inc. (Nasdaq: DATA ) to offer the most compr...utical, biotechnology and medical device companies...Inclinix to leverage DATATRAK,s eClinical(TM) plat...ent Contract Research Organization (CRO). This all...
Other Biology Technology:Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 2Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 3Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 2Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 3Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 4Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 5Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 6Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 7Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 8Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 9Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 10Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 11Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 12Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 13Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 14Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 15Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 16Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 17Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 18Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 19Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 20Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 21DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc. 2DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc. 3DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc. 4
Goat Anti-Bag-1 (K-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Treponema Pallidum IgM ELISA Kit, Single from Bio-Quant Inc.
Treponema Pallidum Total ELISA Kit, Single from Bio-Quant Inc.
Gel Loading Dye (Bromophenol Blue/Glycerol) from Mo Bio Laboratories, Inc.
Biology Products: